β Home
βΉοΈ Info
π§Ύ At a Glance π Core Facts ποΈ Products/Services β Ratings π§βπΌ Executives π¬ My Commentsπ‘ Analytics
π Insights π’ Company Q&A (464) π οΈ Industry Q&A (98) π Competitors π Price Low π Price Swings β‘ SWOT ποΈ PEST π Porter's Five Forces β¨ Score Positive β οΈ Risk Assessment π§© Segmentation π Ά Google Linksπ Ratios
π° Margins π Financial Ratios π± Growth π Enterprise Value π Key Metrics π΅ Dividendsπ§ Tools
β Due DiligenceποΈ Products/Services
are the following:
1. HIV/AIDS medications: Gilead Sciences is a leader in the development and manufacture of medications for the treatment of HIV/AIDS. Some of their most well-known products in this category include Atripla, Truvada, Genvoya, and Biktarvy.
2. Hepatitis C treatments: Gilead Sciences also offers a range of medications for the treatment of hepatitis C, a viral infection that affects the liver. Some of their products in this category include Sovaldi, Harvoni, and Epclusa.
3. Antifungal medications: The company also has a portfolio of antifungal medications, including Ambisome, AmBisome, and Mycostatin, which are used to treat fungal infections.
4. Cardiovascular and respiratory medications: Gilead Sciences produces medications for the management of cardiovascular and respiratory conditions, such as pulmonary arterial hypertension, chronic obstructive pulmonary disease, and cystic fibrosis.
5. Liver disease treatments: In addition to hepatitis C medications, Gilead offers treatments for other liver diseases, such as autoimmune hepatitis and primary biliary cholangitis.
6. Cancer treatments: The company has a focus on developing and producing innovative treatments for several types of cancer, including leukemia, lymphoma, and skin cancer.
7. Cell therapy products: Gilead's cell therapy products, such as Yescarta and Tecartus, are used to treat certain types of cancer by reprogramming a patient's own immune cells to attack cancer cells.
8. COVID-19 treatments: Gilead Sciences has been at the forefront of developing treatments for COVID-19, including the antiviral drug remdesivir.
9. Pre-exposure prophylaxis (PrEP) medication: Gilead's Truvada and Descovy are used as pre-exposure prophylaxis medications for individuals at high risk of HIV infection.
10. Research and development: The company continues to invest in research and development to discover new treatments and expand their product offerings in various therapeutic areas.
See Company Q&A
1. HIV/AIDS medications: Gilead Sciences is a leader in the development and manufacture of medications for the treatment of HIV/AIDS. Some of their most well-known products in this category include Atripla, Truvada, Genvoya, and Biktarvy.
2. Hepatitis C treatments: Gilead Sciences also offers a range of medications for the treatment of hepatitis C, a viral infection that affects the liver. Some of their products in this category include Sovaldi, Harvoni, and Epclusa.
3. Antifungal medications: The company also has a portfolio of antifungal medications, including Ambisome, AmBisome, and Mycostatin, which are used to treat fungal infections.
4. Cardiovascular and respiratory medications: Gilead Sciences produces medications for the management of cardiovascular and respiratory conditions, such as pulmonary arterial hypertension, chronic obstructive pulmonary disease, and cystic fibrosis.
5. Liver disease treatments: In addition to hepatitis C medications, Gilead offers treatments for other liver diseases, such as autoimmune hepatitis and primary biliary cholangitis.
6. Cancer treatments: The company has a focus on developing and producing innovative treatments for several types of cancer, including leukemia, lymphoma, and skin cancer.
7. Cell therapy products: Gilead's cell therapy products, such as Yescarta and Tecartus, are used to treat certain types of cancer by reprogramming a patient's own immune cells to attack cancer cells.
8. COVID-19 treatments: Gilead Sciences has been at the forefront of developing treatments for COVID-19, including the antiviral drug remdesivir.
9. Pre-exposure prophylaxis (PrEP) medication: Gilead's Truvada and Descovy are used as pre-exposure prophylaxis medications for individuals at high risk of HIV infection.
10. Research and development: The company continues to invest in research and development to discover new treatments and expand their product offerings in various therapeutic areas.

π Get full analytics about Gilead Sciences
Sign up for free or log inβ Download "The Checklist Value Investor β A Smarter Way to Pick Stocks" β totally free!